Drugs in Development for Malaria.
- Published in:
- Drugs, 2018, v. 78, n. 9, p. 861, doi. 10.1007/s40265-018-0911-9
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2018 AND VI 78 AND IP 9
Results: 9
1
2
Telotristat Ethyl: A Review in Carcinoid Syndrome Diarrhoea.
- Published in:
- Drugs, 2018, v. 78, n. 9, p. 941, doi. 10.1007/s40265-018-0935-1
- By:
- Publication type:
- Article
3
Correction to: Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab.
- Published in:
- Drugs, 2018, v. 78, n. 9, p. 891, doi. 10.1007/s40265-018-0933-3
- By:
- Publication type:
- Article
4
Regorafenib: A Review in Hepatocellular Carcinoma.
- Published in:
- Drugs, 2018, v. 78, n. 9, p. 951, doi. 10.1007/s40265-018-0932-4
- By:
- Publication type:
- Article
5
Sarilumab: A Review in Moderate to Severe Rheumatoid Arthritis.
- Published in:
- Drugs, 2018, v. 78, n. 9, p. 929, doi. 10.1007/s40265-018-0929-z
- By:
- Publication type:
- Article
6
Fostamatinib: First Global Approval.
- Published in:
- Drugs, 2018, v. 78, n. 9, p. 959, doi. 10.1007/s40265-018-0927-1
- By:
- Publication type:
- Article
7
CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine.
- Published in:
- Drugs, 2018, v. 78, n. 9, p. 913, doi. 10.1007/s40265-018-0923-5
- By:
- Publication type:
- Article
8
Targeting EGFR in Lung Cancer: Current Standards and Developments.
- Published in:
- Drugs, 2018, v. 78, n. 9, p. 893, doi. 10.1007/s40265-018-0916-4
- By:
- Publication type:
- Article
9
Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab.
- Published in:
- Drugs, 2018, v. 78, n. 9, p. 881, doi. 10.1007/s40265-018-0922-6
- By:
- Publication type:
- Article